These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22578558)

  • 1. Cell membrane water exchange effects in prostate DCE-MRI.
    Li X; Priest RA; Woodward WJ; Siddiqui F; Beer TM; Garzotto MG; Rooney WD; Springer CS
    J Magn Reson; 2012 May; 218():77-85. PubMed ID: 22578558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scaling.
    Li X; Cai Y; Moloney B; Chen Y; Huang W; Woods M; Coakley FV; Rooney WD; Garzotto MG; Springer CS
    J Magn Reson; 2016 Aug; 269():104-112. PubMed ID: 27288764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection.
    Li X; Priest RA; Woodward WJ; Tagge IJ; Siddiqui F; Huang W; Rooney WD; Beer TM; Garzotto MG; Springer CS
    Magn Reson Med; 2013 Jan; 69(1):171-8. PubMed ID: 22457233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating the effects of transcytolemmal water exchange in a reference region model for DCE-MRI analysis: theory, simulations, and experimental results.
    Yankeelov TE; Luci JJ; DeBusk LM; Lin PC; Gore JC
    Magn Reson Med; 2008 Feb; 59(2):326-35. PubMed ID: 18228592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.
    Cai W; Li F; Wang J; Du H; Wang X; Zhang J; Fang J; Jiang X
    NMR Biomed; 2014 Jul; 27(7):817-25. PubMed ID: 24809332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal-to-noise ratio, contrast-to-noise ratio and pharmacokinetic modeling considerations in dynamic contrast-enhanced magnetic resonance imaging.
    Li X; Huang W; Rooney WD
    Magn Reson Imaging; 2012 Nov; 30(9):1313-22. PubMed ID: 22795931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Dispersion MRI for Improved Prostate Cancer Diagnosis in a Multicenter Study.
    Turco S; Lavini C; Heijmink S; Barentsz J; Wijkstra H; Mischi M
    AJR Am J Roentgenol; 2018 Nov; 211(5):W242-W251. PubMed ID: 30346837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck.
    Kim S; Quon H; Loevner LA; Rosen MA; Dougherty L; Kilger AM; Glickson JD; Poptani H
    J Magn Reson Imaging; 2007 Dec; 26(6):1607-17. PubMed ID: 17968962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
    J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-pass dynamic contrast-enhanced MRI with extravasating contrast reagent: evidence for human myocardial capillary recruitment in adenosine-induced hyperemia.
    Li X; Springer CS; Jerosch-Herold M
    NMR Biomed; 2009 Feb; 22(2):148-57. PubMed ID: 18727151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI.
    Kiessling F; Lichy M; Grobholz R; Heilmann M; Farhan N; Michel MS; Trojan L; Ederle J; Abel U; Kauczor HU; Semmler W; Delorme S
    Eur Radiol; 2004 Oct; 14(10):1793-801. PubMed ID: 15232714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular-interstitial water exchange and its effect on the determination of contrast agent concentration in vivo: dynamic contrast-enhanced MRI of human internal obturator muscle.
    Buckley DL; Kershaw LE; Stanisz GJ
    Magn Reson Med; 2008 Nov; 60(5):1011-9. PubMed ID: 18956419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.
    Baur ADJ; Schwabe J; Rogasch J; Maxeiner A; Penzkofer T; Stephan C; Rudl M; Hamm B; Jung EM; Fischer T
    Eur Radiol; 2018 May; 28(5):1949-1960. PubMed ID: 29238867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
    Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
    Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: A preliminary comparison to assess the magnitude of water exchange effects.
    Bains LJ; McGrath DM; Naish JH; Cheung S; Watson Y; Taylor MB; Logue JP; Parker GJ; Waterton JC; Buckley DL
    Magn Reson Med; 2010 Aug; 64(2):595-603. PubMed ID: 20665802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI.
    Noworolski SM; Henry RG; Vigneron DB; Kurhanewicz J
    Magn Reson Med; 2005 Feb; 53(2):249-55. PubMed ID: 15678552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge.
    Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
    Tomography; 2016 Mar; 2(1):56-66. PubMed ID: 27200418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.